{"number":"US12697369B2","kindCode":"B2","documentType":"grant","title":{"original":"Targeting CD24-Siglec interactions for the treatment of nonviral hepatitis and liver fibrosis","english":"Targeting CD24-Siglec interactions for the treatment of nonviral hepatitis and liver fibrosis"},"abstract":{"original":"Provided herein are methods and compositions for the prevention and treatment of nonalcoholic steatohepatitis (NASH) by targeting the CD24-Siglec axis.","english":"Provided herein are methods and compositions for the prevention and treatment of nonalcoholic steatohepatitis (NASH) by targeting the CD24-Siglec axis."},"applicants":["University of Maryland, Baltimore","Oncolmmune, Inc."],"inventors":["Yang Liu","Pan Zheng","Xu Wang","Mingyue Liu","Martin Devenport"],"filingDate":"2021-08-05","publicationDate":"2026-08-04","grantDate":"2026-08-04","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12697369B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12697369B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12697369B2","ja":"https://downloadpatent.com/ja/patent/US12697369B2"}}